Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-053100
Filing Date
2012-11-14
Accepted
2012-11-14 19:29:39
Documents
1
Period of Report
2012-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5753
  Complete submission text file 0001209191-12-053100.txt   7370
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
Biota Pharmaceuticals, Inc. (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address
PLUMB RUSSELL H (Reporting) CIK: 0001283216 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 121206325